Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,256,818
  • Shares Outstanding, K 211,176
  • Annual Sales, $ 2,090 M
  • Annual Income, $ 424,880 K
  • EBIT $ 466 M
  • EBITDA $ 663 M
  • 60-Month Beta 0.67
  • Price/Sales 4.88
  • Price/Cash Flow 14.40
  • Price/Book 2.74

Options Overview Details

View History
  • Implied Volatility 54.68% (-1.57%)
  • Historical Volatility 50.09%
  • IV Percentile 95%
  • IV Rank 77.66%
  • IV High 64.57% on 11/11/25
  • IV Low 20.32% on 08/21/25
  • Expected Move (DTE 27) 5.10 (10.50%)
  • Put/Call Vol Ratio 0.63
  • Today's Volume 1,040
  • Volume Avg (30-Day) 3,495
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 86,815
  • Open Int (30-Day) 48,525
  • Expected Range 43.47 to 53.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.55
  • Number of Estimates 6
  • High Estimate 0.58
  • Low Estimate 0.54
  • Prior Year 0.58
  • Growth Rate Est. (year over year) -5.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.96 +1.27%
on 02/20/26
56.19 -13.56%
on 01/26/26
-6.88 (-12.41%)
since 01/20/26
3-Month
46.07 +5.43%
on 01/20/26
57.81 -15.99%
on 01/20/26
+0.50 (+1.03%)
since 11/20/25
52-Week
39.61 +22.62%
on 03/04/25
57.81 -15.99%
on 01/20/26
+7.97 (+19.63%)
since 02/20/25

Most Recent Stories

More News
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery

New chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole...

QGEN : 48.57 (+0.52%)
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars

Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.62 ...

QGEN : 48.57 (+0.52%)
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026

QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features ...

QGEN : 48.57 (+0.52%)
QIAGEN Appoints Mark Stevenson to Supervisory Board

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Mark Stevenson has been appointed as an independent member of the Supervisory Board as of January 23, 2026, and will stand for election...

QGEN : 48.57 (+0.52%)
Stocks Settle Higher as Global Tensions Cool and the Economy Expands

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.76%. March E-mini...

GOOGL : 314.98 (+4.01%)
SPHR : 114.24 (-0.91%)
ANET : 132.79 (-3.24%)
AAPL : 264.58 (+1.54%)
HBAN : 18.01 (+0.90%)
MBLY : 9.05 (-1.52%)
DDOG : 115.66 (-4.10%)
$IUXX : 25,012.62 (+0.87%)
ASML : 1,469.59 (+0.73%)
ZNH26 : 112-300s (-0.03%)
MSFT : 397.23 (-0.31%)
TSLA : 411.82 (+0.03%)
Stocks Supported by Easing Geopolitical Tensions and Solid US Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.59%. March E-mini S&P futures (ESH26...

GOOGL : 314.98 (+4.01%)
SPHR : 114.24 (-0.91%)
AAPL : 264.58 (+1.54%)
ADI : 355.03 (+2.82%)
HBAN : 18.01 (+0.90%)
MBLY : 9.05 (-1.52%)
DDOG : 115.66 (-4.10%)
$IUXX : 25,012.62 (+0.87%)
ASML : 1,469.59 (+0.73%)
ZNH26 : 112-300s (-0.03%)
MSFT : 397.23 (-0.31%)
TSLA : 411.82 (+0.03%)
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the fourth quarter of 2025. Press release date / time: Wednesday, February 4...

QGEN : 48.57 (+0.52%)
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined annual pillar sales in 2028

QGEN : 48.57 (+0.52%)
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million

Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026 Capital return...

QGEN : 48.57 (+0.52%)
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 ...

QGEN : 48.57 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed...

See More

Key Turning Points

3rd Resistance Point 49.63
2nd Resistance Point 49.18
1st Resistance Point 48.87
Last Price 48.57
1st Support Level 48.11
2nd Support Level 47.66
3rd Support Level 47.35

See More

52-Week High 57.81
Fibonacci 61.8% 50.86
Fibonacci 50% 48.71
Last Price 48.57
Fibonacci 38.2% 46.56
52-Week Low 39.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar